Difference between revisions of "Team:Technion Israel/Collaborations"

(Prototype team page)
 
Line 1: Line 1:
−
{{Technion_Israel}}
+
{{Template_All_Teams}}
 
<html>
 
<html>
 +
<head>
 +
<meta charset="utf-8"/>
 +
 +
<link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Technion/CSS?action=raw&ctype=text/css" />
 +
 +
<title>Team: Technion 2015</title>
 +
</head>
 +
<body>
  
−
<h2> Collaborations</h2>
+
<header>
 +
 +
<img src="https://static.igem.org/mediawiki/2015/f/fc/Team_Technion_Logo.png" alt="Team Logo" id="team_logo" />
  
−
<p>
+
<div class="main_menu">
−
Sharing and collaboration are core values of iGEM. We encourage you to reach out and work with other teams on difficult problems that you can more easily solve together.
+
<nav>
−
</p>
+
<a href="#">
 +
<button class="button_main1">
 +
<span class="btn-text">Project</span>
 +
<span class="btn-bg"></span>
 +
</button>
 +
</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Lab_Notebook">
 +
<button class="button_main2">
 +
<span class="btn-text">Lab Notebook</span>
 +
<span class="btn-bg"></span>
 +
</button>
 +
</a>
 +
<a href="#">
 +
<button class="button_main3">
 +
<span class="btn-text">Judging Criteria</span>
 +
<span class="btn-bg"></span>
 +
</button>
 +
</a>
 +
<a href="#">
 +
<button class="button_main4">
 +
<span class="btn-text">Human Practices</span>
 +
<span class="btn-bg"></span>
 +
</button>
 +
</a>
 +
<a href="#">
 +
<button class="button_main5">
 +
<span class="btn-text">Team</span>
 +
<span class="btn-bg"></span>
 +
</button>
 +
</a>
 +
</nav>
 +
</div>
 +
</header>
  
−
<div class="highlightBox">
+
<!---------------------------------------dropdown menu----------------------------------->
 +
<div class="dropdown">
 +
<a href="https://2015.igem.org/Team:Technion_Israel">
 +
<img src="https://static.igem.org/mediawiki/2015/c/c1/Team_Technion_Navbar_Home.png" alt="Home" id="home_nav" />
 +
<div id="home_text">Navigate</div>
 +
</a>
 +
<nav>
 +
<div class="main1">
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Project">Project</a>
 +
<span class="btn-bg1"></span>
 +
<div class="sub1">
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Project/Overview">Overview</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Project/Bacillus">Bacillus</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Project/E_Coli">E.Coli</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Project/NADPH">NADPH</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Project/Comb">Comb</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Modeling">Modeling</a>
 +
</div>
 +
</div>
 +
<div class="main2">
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Team">Team</a>
 +
<span class="btn-bg2"></span>
 +
<div class="sub2">
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Team/About_Us">About&nbsp;Us</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Attributions">Attributions</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Team/Sponsors">Sponsors</a>
 +
</div>
 +
</div>
 +
<div class="main3">
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Lab_Notebook">Lab&nbsp;Notebook</a>
 +
<span class="btn-bg3"></span>
 +
<div class="sub3">
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Lab_Notebook/Overview">Overview</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Lab_Notebook/Protocols">Protocols</a>
 +
</div>
 +
</div>
 +
<div class="main4">
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Practices">Human&nbsp;Practices</a>
 +
<span class="btn-bg4"></span>
 +
<div class="sub4">
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Practices/Education">Education</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Practices/Publications">Publications</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Practices/Market_Research">Market&nbsp;Research</a>
 +
</div>
 +
</div>
 +
<div class="main5">
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Judging_Criteria">Judging&nbsp;Criteria</a>
 +
<span class="btn-bg5"></span>
 +
<div class="sub5">
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Parts">Parts</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Judging_Criteria/Achievements">Achievements</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Collaborations">Collaborations</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Design">Design</a>
 +
<a href="https://2015.igem.org/Team:Technion_Israel/Entrepreneurship">Entrepreneurship</a>
 +
</div>
 +
</div>
 +
</nav>
 +
</div>
 +
<!---------------------------------------dropdown menu-end----------------------------------->
  
−
<h4> Which other teams can we work with? </h4>
+
<div class="content">
−
<p>  
+
<h1 class="abstract_title">Hello! Welcome to our temporary wiki page!</h1>
−
You can work with any other team in the competition, including software, hardware, high school and other tracks. You can also work with non-iGEM research groups, but they do not count towards the <a hreef="https://2015.igem.org/Judging/Awards#Medals">iGEM team collaboration gold medal criterion</a>.
+
<div class="abstract">
−
</p>
+
<b>Our team is developing a treatment for male pattern baldness.</b>
−
 
+
<p>
−
<p>
+
Hair loss affects roughly 61 million people in the United States.  More than 95% of hair thinning in men is attributed to male pattern baldness, or androgenetic alopecia.  The hair loss product market is a multi-billion dollar market: in the United States alone, this market’s annual revenue is 7 billion dollars, with 3.5% annual growth rate from 2007 to 2012, yet a sufficient solution has yet to be made available.
−
In order to meet the gold medal criteria on helping another team, you must complete this page and detail the nature of your collaboration with another iGEM team.
+
The trigger for androgenetic alopecia is believed to be dihydrotestosterone (DHT), a derivative of testosterone.
−
</p>
+
This summer, we are engineering Bacillus Subtilis, a model organism for a bacterium found naturally on the scalp, to secrete 3α-hydroxysteroid dehydrogenase (3-α-HSD).  This enzyme reduces DHT to a non-steroidically active compound, using NADPH and NADH as cofactors.
 +
</p>
 +
<p>
 +
Our project consists of 3 main parts: 3-α-HSD secretion by the bacterium, engineered bacterium for NADPH overproduction, and a comb as a tool to create a user-friendly experience.
 +
By synchronizing these parts, we hope to be able to show convincing evidence of DHT breakdown, providing a promising platform for treatment of male pattern baldness!
 +
</p>
 +
</div>
 
</div>
 
</div>
  
−
<p>
+
<footer>
−
Here are some suggestions for projects you could work on with other teams:
+
<div class="team_name">
−
</p>
+
<h3>Contact Us</h3>
 +
</div>
 +
<nav class="connect_links">
 +
<div class="facebook_link">
 +
<a href="https://www.facebook.com/technioniGEM2015?pnref=story" target="_blank">
 +
<img src="https://static.igem.org/mediawiki/2015/0/06/Team_Technion_Footer_facebook.png" alt="Follow us on facebook" /></a>
 +
</div>
 +
<div class="email_link">
 +
<a href="mailto:igem.technion2015@gmail.com">
 +
<img src="https://static.igem.org/mediawiki/2015/d/da/Team_Technion_Footer_gmail.png" alt="Send us an Email" /></a>
 +
</div>
 +
</nav>
 +
</footer>
  
−
<ul>
+
<script type="text/javascript" src="jquery-1.8.0.min.js"></script>
−
<li> Improve the function of another team's BioBrick Part or Device</li>
+
<script type="text/javascript" src="https://2015.igem.org/Template:Technion/Javascript?
−
<li> Characterize another team's part </li>
+
action=raw&ctype=text/javascript"></script>
−
<li> Debug a construct </li>
+
</body>
−
<li> Model or simulating another team's system </li>
+
−
<li> Test another team's software</li>
+
−
<li> Help build and test another team's hardware project</li>
+
−
<li> Mentor a high-school team</li>
+
−
</ul>
+
−
 
+
−
 
+
−
 
+
−
</div>
+
 
</html>
 
</html>

Revision as of 10:28, 30 August 2015

Team: Technion 2015

Home
Navigate

Hello! Welcome to our temporary wiki page!

Our team is developing a treatment for male pattern baldness.

Hair loss affects roughly 61 million people in the United States. More than 95% of hair thinning in men is attributed to male pattern baldness, or androgenetic alopecia. The hair loss product market is a multi-billion dollar market: in the United States alone, this market’s annual revenue is 7 billion dollars, with 3.5% annual growth rate from 2007 to 2012, yet a sufficient solution has yet to be made available. The trigger for androgenetic alopecia is believed to be dihydrotestosterone (DHT), a derivative of testosterone. This summer, we are engineering Bacillus Subtilis, a model organism for a bacterium found naturally on the scalp, to secrete 3α-hydroxysteroid dehydrogenase (3-α-HSD). This enzyme reduces DHT to a non-steroidically active compound, using NADPH and NADH as cofactors.

Our project consists of 3 main parts: 3-α-HSD secretion by the bacterium, engineered bacterium for NADPH overproduction, and a comb as a tool to create a user-friendly experience. By synchronizing these parts, we hope to be able to show convincing evidence of DHT breakdown, providing a promising platform for treatment of male pattern baldness!

Contact Us